← Back to Clinical Trials
Recruiting NCT07810686

NCT07810686 Smartphone AI Assistance for Prehospital ECG Interpretation

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT07810686
Status Recruiting
Phase
Sponsor École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care
Condition Acute Coronary Syndromes
Study Type INTERVENTIONAL
Enrollment 144 participants
Start Date 2026-09-02
Primary Completion 2026-11-30

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Smartphone large language model assistance (GPT-4o, version-locked)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 144 participants in total. It began in 2026-09-02 with a primary completion date of 2026-11-30.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Prehospital providers interpret 12-lead electrocardiograms (ECGs) under time pressure and without immediate expert support. Missed acute coronary occlusion - occlusion myocardial infarction (OMI) - delays reperfusion, while false positive interpretations trigger unnecessary catheterization laboratory activations. Multimodal large language models (LLMs) available on any smartphone can now analyze a photographed ECG, and prehospital providers have begun using them spontaneously. No randomized trial has evaluated whether this practice improves diagnostic performance. This randomized controlled trial compares the diagnostic performance of prehospital providers interpreting ECG clinical vignettes with and without mandatory assistance from a single, version-locked smartphone large language model. Participants - paramedics, emergency medical technicians, nurses and physicians practicing in prehospital care in French-speaking Switzerland - are randomized 1:1 on a dedicated digital platform and answer 14 clinical vignettes presented in individually randomized order. Each vignette is built around a real, anonymized 12-lead ECG obtained during routine clinical care. The primary outcome is the proportion of vignettes for which the participant correctly identifies the presence or absence of an OMI. Secondary outcomes are sensitivity, specificity, and the accuracy of the prehospital priority decision level.

Eligibility Criteria

Inclusion Criteria: * Prehospital care provider practising in French-speaking Switzerland * Any level of training: emergency medical technician, paramedic (ES), nurse (ES/HES) in prehospital emergency care, or prehospital emergency physician * Electronic informed consent signed before randomization Exclusion Criteria: * Cardiologist * Any person not practising in prehospital care * Insufficient command of written French to answer the vignettes reliably * Refusal to participate or withdrawal of consent

Contact & Investigator

Central Contact

Laurent Bourgeois

✉ laurent.bourgeois@edu.ge.ch

📞 +41 22 388 34 04

Frequently Asked Questions

Who can join the NCT07810686 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Acute Coronary Syndromes. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT07810686 currently recruiting?

Yes, NCT07810686 is actively recruiting participants. Contact the research team at laurent.bourgeois@edu.ge.ch for enrollment information.

Where is the NCT07810686 trial being conducted?

This trial is being conducted at Murten/Morat, Switzerland.

Who is sponsoring the NCT07810686 clinical trial?

NCT07810686 is sponsored by École Supérieure de Soins Ambulanciers - College of Higher Education in Prehospital Care. The trial plans to enroll 144 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology